Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

NCT01454531 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT01454531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01454531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
Lead sponsor
ALK-Abelló A/S
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2011
Completion date
April 30, 2012
Enrollment
199 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis